176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.55%
Revenue decline while MRVL shows 7.04% growth. Joel Greenblatt would examine competitive position erosion.
-4.39%
Cost reduction while MRVL shows 4.79% growth. Joel Greenblatt would examine competitive advantage.
3.51%
Gross profit growth below 50% of MRVL's 9.12%. Michael Burry would check for structural issues.
5.14%
Margin expansion exceeding 1.5x MRVL's 1.94%. David Dodd would verify competitive advantages.
-0.12%
R&D reduction while MRVL shows 1.76% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.63%
Operating expenses growth 1.1-1.25x MRVL's 2.32%. Bill Ackman would demand justification.
-2.54%
Total costs reduction while MRVL shows 3.79% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-0.48%
D&A reduction while MRVL shows 1.08% growth. Joel Greenblatt would examine efficiency.
34.37%
EBITDA growth exceeding 1.5x MRVL's 14.38%. David Dodd would verify competitive advantages.
5.48%
Similar EBITDA margin growth to MRVL's 6.85%. Walter Schloss would investigate industry trends.
5.06%
Operating income growth below 50% of MRVL's 20.91%. Michael Burry would check for structural issues.
6.71%
Operating margin growth 50-75% of MRVL's 12.96%. Martin Whitman would scrutinize operations.
19.35%
Similar other expenses growth to MRVL's 21.37%. Walter Schloss would investigate industry patterns.
5.84%
Pre-tax income growth below 50% of MRVL's 20.94%. Michael Burry would check for structural issues.
7.50%
Pre-tax margin growth 50-75% of MRVL's 12.98%. Martin Whitman would scrutinize operations.
-35.33%
Tax expense reduction while MRVL shows 15.93% growth. Joel Greenblatt would examine advantage.
16.13%
Net income growth 50-75% of MRVL's 21.67%. Martin Whitman would scrutinize operations.
17.95%
Net margin growth 1.25-1.5x MRVL's 13.67%. Bruce Berkowitz would examine sustainability.
15.63%
Similar EPS growth to MRVL's 16.67%. Walter Schloss would investigate industry trends.
10.00%
Diluted EPS growth below 50% of MRVL's 30.00%. Michael Burry would check for structural issues.
0.18%
Share count reduction exceeding 1.5x MRVL's 0.76%. David Dodd would verify capital allocation.
0.19%
Diluted share reduction exceeding 1.5x MRVL's 0.76%. David Dodd would verify capital allocation.